Orca Bio is helping to deliver the promise of cell therapy to patients without compromise. Backed by Lightspeed and Felicis.
About the role
Position Summary: We are seeking a Medical Director / Senior Medical Director (depending on experience) to serve as medical lead for our next-generation cell therapy program (Orca-Q) late-stage study. This role is critical in conceptualizing our Pivotal Phase 3 study, developing the associated protocols, analyzing data, and conducting the clinical trial. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- MD required, preferably a trained bone marrow transplant (BMT) physician, hematologist and/or oncologist
- 3+ years of industry experience and expertise in cell therapy, BMT, or immune disorders preferred, including experience implementing randomized registrational studies
- Self starter with an entrepreneurial mindset
- Strong project management skills, with the ability to handle multiple priorities and timelines, work independently and drive initiatives
- Excellent verbal and written communication skills, with the ability to engage and motivate clinical site teams
- Willingness to travel as needed to meet with clinical sites and stakeholders
More about this role
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a commercial-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
Position Summary: We are seeking a Medical Director / Senior Medical Director (depending on experience) to serve as medical lead for our next-generation cell therapy program (Orca-Q) late-stage study. This role is critical in conceptualizing our Pivotal Phase 3 study, developing the associated protocols, analyzing data, and conducting the clinical trial. The candidate must work collaboratively within Orca Bio and also with principal investigators (PIs) nationwide to progress the program towards product registration.
- Support strategic...
Browse similar: Startup jobs · San Francisco Bay Area